Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NMNAT3 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
mRNA | ATRX | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
mRNA | ARFGEF3 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.05 |
mRNA | INTU | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
mRNA | TMEM211 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
mRNA | DST | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |
mRNA | SLC25A43 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
mRNA | MNT | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
mRNA | ACVR1C | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
mRNA | ZNF622 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |